Chronic partial unloading restores β-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts  by Wang, Jian et al.
Wang et al Cardiopulmonary Support and PhysiologyChronic partial unloading restores b-adrenergic responsiveness and
reverses receptor downregulation in failing rat hearts
Jian Wang, MD,a Masaki Tsukashita, MD,a Takeshi Nishina, MD, PhD,a Akira Marui, MD, PhD,a Eiji Yoshikawa, MD,a
Hiroyuki Muranaka, MD,a Satoshi Matsuoka, MD, PhD,b and Tadashi Ikeda, MD, PhDa
Objectives: Mechanical unloading with a left ventricular assist device promotes ‘‘reverse remodeling,’’ includ-
ing restoration of b-adrenergic receptor signaling and function. We compared the effects of partial unloading and
complete unloading on b-adrenergic responsiveness and gene expressions in failing rat hearts by use of hetero-
topic heart–lung or heart transplantation models.
Methods: Four weeks after ligation of the left anterior descending artery in Lewis rats, rats with heart failure were
divided into 3 groups: infarcted hearts and lungs transplanted into the recipient rats (heart failure–partial unload-
ing, n ¼ 8); infarcted hearts transplanted into the recipient rats (heart failure–complete unloading, n ¼ 7); in-
farcted (heart failure, n ¼ 8) hearts without transplantation. Normal rats (n ¼ 7) were used as controls.
Papillary muscle function and gene expressions were studied at 2 or 4 weeks after transplantation.
Results: In 2-week models, baseline developed tension of papillary muscles significantly increased in heart
failure–partial unloading and heart failure–complete unloading compared with heart failure (0.15  0.07 and
0.12  0.05 g/mm2 vs 0.02  0.01 g/mm2, P<.05). However, in 4-week models, they decreased to 0.11  0.03
and 0.10  0.03 g/mm2. In 4-week but not in 2-week models, the increase from baseline in baseline developed
tension produced by b-adrenergic stimulation (isoproterenol, 108 and 107 mol/L) was significantly increased
in heart failure–partial unloading compared with heart failure–complete unloading and heart failure (P< .05).
The mRNA expressions of brain natriuretic peptide and b1- and b2-adrenergic receptors were normalized in
both 2- and 4-week models of heart failure–partial unloading.
Conclusions: Chronic partial unloading but not complete unloading improved b-adrenergic responsiveness and
normalized brain natriuretic peptide and b1- and b2-adrenergic receptor mRNA expressions in the failing rat
hearts.C
S
PRecent evidence indicates that hemodynamic unloading and
left ventricle rest via left ventricular (LV) assist devices
(LVADs) can lead to normalization of myocardial structure
and function in patients with end-stage heart failure (HF),
which is known as ‘‘reverse remodeling.’’1,2 In some cases,
LVADs can eventually be explanted, and heart transplanta-
tion is no longer necessary.3 Although the functional out-
comes of LVAD-induced unloading are described, clinical
success of achieving sustained recovery of the end-stage
failing heart has been sporadic, and the mechanisms of an
LVAD as a bridge to recovery remain unknown.
On the other hand, to investigate the effects of mechanical
unloading of the left ventricle, other than studies of human
heart samples at the time of transplantation, some animal
studies of heterotopic heart transplantation (ie, complete un-
loading) model have examined the effects of LV unloading
on the failing hearts.4,5 However, no blood is drained into the
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ities were entirely shunted, and the left ventricle was com-
pletely unloaded. Recently, a new heterotopic heart–lung
transplantation (ie, partial unloading) model was reported
to simulate the mechanical unloading.6 In this model, the
left ventricle was loaded only with the coronary venous
blood, which creates partial unloading. In our previous
study,7 we examined the effects of partial unloading on fail-
ing rat heart in a 2-week model. However, long-term effects
of partial unloading and the differences to complete unload-
ing are unknown. In this study, we compared contractility
of isolated papillary muscle at baseline and after inotropic
stimulation by isoproterenol, as well as gene expressions
in failing rat hearts under partial unloading and complete
unloading in both 2- and 4-week models.
MATERIALS AND METHODS
Animal Model
Inbred male Lewis rats weighing 150 to 200 g (Japan SLC Inc, Hama-
matsu, Japan) were used in this study. All animals were bred under cli-
mate-controlled conditions with 12-hour light–dark cycle and provided
with standardized rat chow and water. All experimental procedures were hu-
manely performed according to the institutional guidelines on animal exper-
imentation of Kyoto University.
HF Model. HF was induced by the ligation of left anterior descending
(LAD) artery as previously described.5 In brief, Lewis rats were anesthe-
tized with 1% isoflurane on a volume-cycled ventilator for small animals.ardiovascular Surgery c Volume 137, Number 2 465
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PAbbreviations and Acronyms
ANOVA ¼ analysis of variance
AR ¼ adrenergic receptor
BNP ¼ brain natriuretic peptide
DT ¼ development tension
FAC ¼ fractional area change
GAPDH ¼ glyceraldehyde 3-phosphate
dehydrogenase
HF ¼ heart failure
HF-CU ¼ heart failure–complete unloading
HF-PU ¼ heart failure–partial unloading
LAD ¼ left anterior descending
LV ¼ left ventricular
LVAD ¼ left ventricular assist device
LVDd ¼ left ventricular end-diastolic dimension
LVEDA ¼ left ventricular end-diastolic area
LVESA ¼ left ventricular end-systolic area
MI ¼ myocardial infarction
PCR ¼ polymerase chain reaction
SERCA2a ¼ sarco(endo)plasmic reticulum
Ca2þ-ATPase2a
Anterior myocardial infarction (MI) was created by the ligation of LAD near
the main pulmonary. Four weeks after the ligation of LAD, LV function and
infarct size were evaluated by echocardiography with a 12-MHz phased
array transducer (HP SONOS 4500, Agilent Technologies, Andover, MA).
B-mode measurement in the LV short axis view (papillary muscle level)
was performed. Left ventricular end-diastolic area (LVEDA) and left ventric-
ular end-systolic area (LVESA) were measured by tracing the endocardial bor-
der. Fractional area change (FAC), an index of LV systolic function, was
calculated by this equation: FAC (%) ¼ (LVEDA LVESA)/LVEDA 3
100. LV end-diastolic dimension (LVDd) was recorded by M-mode. Infarct
size (%) was calculated as (infarct length in LV diastolic phase)/(LV diastolic
circumference)3 100. Three measurements were taken and averaged to cal-
culate these parameters during each examination.
Partial Unloading Model. The donor heart and lungs were har-
vested after ligation of left and right superior vena cava and the inferior
vena cava and transection of the ascending aorta and the trachea. The as-
cending aorta of the donor heart was anastomosed end-to-side to the abdom-
inal aorta of the recipient. Once the abdominal aorta was declamped, the
donor heart was perfused through the coronary arteries and started beating.
Only the coronary venous blood entered the left ventricle through the coro-
nary sinus, the right atrium, the right ventricle, the pulmonary artery, the
lungs, the pulmonary veins, and the left atrium. Therefore, the left ventricle
was partially unloaded.
Complete Unloading Model. The donor heart was harvested after
ligation of the pulmonary veins and both vena cava and transection of the
ascending aorta and main pulmonary artery. The ascending aorta of the
donor heart was anastomosed end-to-side to the abdominal aorta of the re-
cipient, and the pulmonary artery of the donor heart was anastomosed
end-to-side to the inferior vena cava of the recipient. Coronary venous blood
was drained into the right atrium and the right ventricle and ejected into the
pulmonary artery and the recipient inferior vena cava. Thus, left heart cav-
ities were entirely shunted and the left ventricle was completely unloaded.
After heterotopic transplantation, most of the rats survived with an oper-
ative mortality of less than 5%.466 The Journal of Thoracic and Cardiovascular SuStudy Protocol
Four weeks after the ligation of LAD, rats with HF (infarct size>30%)
were randomly divided into 3 groups: in the HF–partial unloading group
(HF-PU group, n ¼ 8 each), the infarcted hearts and lungs were heterotopi-
cally transplanted into the abdomen of recipient rats; in the HF–complete
unloading group (HF-CU, n¼ 7 each), the infarcted hearts were heterotopi-
cally transplanted into the abdomen of recipient rats; in the HF group (n¼ 8
each), the hearts were not transplanted. Animals were studied at either 2
weeks or 4 weeks after transplantation. Normal rats were used as controls
(control group, n ¼ 7).
Isolated Papillary Muscle Function
Papillary muscle function was examined at experimental end points as
described elsewhere.8 Rats were anesthetized with pentobarbital sodium
(100 mg/kg) via intraperitoneal injection and heparinized (500 U) via intra-
venous infusion. After opening the abdomen, the heart was quickly excised
and placed into normal Tyrode’s solution containing (in mmol/L) Naþ142,
Kþ5.6, Mg2þ1, Cl154.6, HEPES 5, and glucose 11. Noninfarcted posterior
papillary muscle was carefully ligated with a silk thread, dissected from the
LV wall, and mounted in a tissue bath containing Krebs-Henseleit solution
(in mmol/L) Naþ 152, Kþ 3.6, Mg2þ 0.6, Ca2þ 2.5, Cl 135, HCO3
 25,
H2PO4
 1.3, SO4
2 0.6, glucose 5.6, and 2, 3-butanedione monoxime 30,
pH 7.4. The bath was maintained at a constant temperature of 37C and bub-
bled with 95% O2 and 5% CO2. The papillary muscle was stimulated at 1
Hz with impulses of 5-ms duration by use of field stimulation delivered
through a pair of electrodes placed parallel to the muscle. Five-millisecond
pluses at a voltage approximately 10% above threshold level were used.
The papillary muscle was stretched to the length at which maximal tension
occurred. After stabilization, isometric tension was recorded digitally at the
maximum tension position, and papillary muscle diameter was measured
with a calibrated eyepiece. Isometric contraction parameters of 10 twitches
were averaged and development tension (DT) was normalized for muscle
cross-sectional area in square millimeters.
After baseline measurements were finished, DT was recorded during
exposure to the b-adrenergic agonist isoproterenol. Isoproterenol HCl was
dissolved in perfusate to produce cumulative concentrations of 108 and
107 mol/L. DT was measured when the response was maximal.
After removal of the papillary muscle from the heart, the LV myocar-
dium was transversely sliced into 2-mm-diameter sections at the base of
the papillary muscle and fixed in 10% buffered formalin. The remaining
LV myocardium was frozen at80C until analyzed.
Determination of Cardiomyocyte Diameter and
Analysis of mRNA Expression
Transverse sections of LV myocardium were stained with hematoxylin–
eosin to measure cardiomyocyte diameter. The mean cardiomyocyte
diameters were calculated by measurement of 50 cells in the remote area
of infarction under microscopy (magnification 3400) to avoid the direct
influence of myocardial necrosis and fibrosis. Cells were accepted for mea-
surement if they met the following criteria: (1) cross sections of cardiomyo-
cytes were present, (2) cardiomyocytes had a visible nucleus, and (3) their
cellular membranes were intact.5
Expression of specific mRNA was determined using the ABI PRISM
7700 sequence detection system (Applied Biosystems, Warrington, UK).
Polymerase chain reaction (PCR) conditions were 40 cycles of denaturing
at 94C for 20 seconds and primer annealing/extension at 62C for 60 sec-
onds. The PCR sequences of brain natriuretic peptide (BNP), sarco(endo)-
plasmic reticulum Ca2þ-ATPase2a (SERCA2a), and b1- and b2-adrenergic
receptors (ARs) were previously reported in our studies.5,8 The TaqMan
rodent glyceraldehyde 3-phosphate dehydrogenase (GAPDH) control re-
agent was used to detect rat GAPDH as the internal standard. Expression
levels of the target gene were normalized to the GAPDH level in each
sample.rgery c February 2009
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Control
(n ¼ 7)
HF (2 wk),
n ¼ 8
HF-PU (2 wk),
n ¼ 8
HF-CU (2 wk),
n ¼ 7
HF (4 wk),
n ¼ 8
HF-PU (4 wk),
n ¼ 8
HF-CU (4 wk),
n ¼ 7
LVDd (cm) 0.65  0.09 0.94  0.05* 0.96  0.07* 1.01  0.06* 0.96  0.04* 0.95  0.03* 0.98  0.09*
FAC (%) 58.32  3.61 32.71  2.14* 30.35  2.54* 31.26  1.59* 31.05  3.24* 32.71  3.59* 31.71  1.82*
Infarct size (%) 0 31.27  1.74* 31.58  1.24* 30.36  1.13* 31.37  1.48* 30.96  1.62* 31.23  1.27*
HF, Heart failure; PU, partial unloading; CU, complete unloading; LVDd, left ventricular end-diastolic dimension; FAC, fractional area change. *P< .05 versus control group.C
S
PData Analysis
All data are expressed as means  standard deviations. Differences
among groups were evaluated by one-way analysis of variance (ANOVA)
followed by a post hoc test. Two-way ANOVA with repeated measures
was used to assess the inotropic response to isoproterenol. Statistical anal-
yses were performed using Statview for Windows version 5.0 (SAS Institute
Inc, Cary, NC). Statistical significance was accepted at the level of P<.05.
RESULTS
Assessment of HF Baseline Echocardiographic Data
The baseline echocardiographic data are shown in Table
1. Four weeks after the ligation of LAD, LVDd and FAC
were significantly impaired in the HF, HF-PU, and HF-CU
groups compared with the control group. There were no
significant differences at baseline and at pretreatment in
LVDd, FAC, and MI size among the HF, HF-PU, and HF-
CU groups before transplantation.
LV Weight and Cardiomyocyte Diameter
LV weight and cardiomyocyte diameter (Table 2) were
lower in both the HF-PU and HF-CU groups than in the
HF group at 2 weeks after transplantation, and there were
no statistical differences with the control group. At 4 weeks
after transplantation, they were also lower in both the HF-PU
and HF-CU groups than in the HF group. However, histo-
logic finding showed that cardiomyocyte became atrophied
in the HF-CU group and remained at normal level in the
HF-PU group.
Baseline DT and b-adrenergic Responsiveness of
Isolated Papillary Muscle
Average contractility of papillary muscle at baseline is
presented in Table 2. At 2 weeks after transplantation,
DTs were higher in both the HF-PU and HF-CU groups
than in the HF group, and there were no statistical differ-
ences with the control group. But at 4 weeks after transplan-
tation, DT in both the HF-PU and HF-CU groups were lower
than in the control group. The inotropic response to isopro-The Journal of Thoracic and Cterenol is shown in Figure 1. At 2 weeks after transplanta-
tion, the increase from baseline in DT produced by
b-adrenergic stimulation (isoproterenol 108 and 107 mol/
L) was improved in papillary muscle from the HF-PU group,
but there were no statistical differences with the HF-CU and
HF groups. At 4 weeks after transplantation, the increase
was significantly improved in the HF-PU group compared
with muscles from the HF-CU and HF groups (isoproterenol
108 mol/L: 25.64%  10.11% vs 13.63%  4.63% and
10.51%  4.35%, P< .05) and (isoproterenol 107 mol/
L: 33.39%  20.17% vs 10.12%  4.45% and 11.54%
 6.66%, P< .05).
Myocardial Expressions of BNP and SERCA2a
mRNAs
The mRNA expression of BNP (Table 3) was lower in
both the HF-PU and HF-CU groups than in the HF group
at 2 weeks after transplantation, and there were no statistical
differences with the control group. However, this expression
was higher in the HF-CU group than in the HF-PU and con-
trol groups at 4 weeks after transplantation. In contrast, there
was no statistical difference between the HF-PU and control
groups.
At 2 weeks after transplantation, the SERCA2a expres-
sion (Table 3) was higher in both the HF-PU and HF-CU
groups than in the HF group, and there were no statistical
differences with the control group. At 4 weeks after trans-
plantation, it was lower in both the HF-PU and HF-CU
groups than in the control group.
Myocardial Expressions of b1- and b2-ARs mRNAs
As shown in Table 3, at 2 and 4 weeks after transplanta-
tion, the mRNA expression of b1-AR was higher in the
HF-PU group than in the HF-CU and HF groups. The
mRNA expression of b2-AR was normalized in the HF-PU
and HF-CU groups at 2 weeks after transplantation (Table
3). However, at 4 weeks after transplantation, b2-ARTABLE 2. LV weight, myocyte diameter, and developed tension
Control
(n ¼ 7)
HF (2 wk),
n ¼ 8
HF-PU (2 wk),
n ¼ 8
HF-CU (2 wk),
n ¼ 7
HF (4 wk),
n ¼ 8
HF-PU (4 wk),
n ¼ 8
HF-CU (4 wk),
n ¼ 7
LV weight (g) 0.57  0.04 0.85  0.04* 0.57  0.05y 0.53  0.06y 0.81  0.05* 0.52  0.05y 0.46  0.07*y
Myocyte diameter (mm) 19.93  0.80 27.34  1.46* 20.17  1.61y 18.76  0.45y 30.13  1.37* 19.08  0.90y 17.54  0.84*y
Developed tension (g/mm2) 0.21  0.07 0.02  0.01* 0.15  0.07y 0.12  0.05y 0.01  0.01* 0.11  0.03*y 0.10  0.03*y
HF, Heart failure; PU, partial unloading; CU, complete unloading; LV, left ventricle. *P< .05 versus control group, yP< .05 versus HF group at the same time point.ardiovascular Surgery c Volume 137, Number 2 467
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PFIGURE 1. Inotropic response to isoproterenol (the increase in developed tension) as a percentage of baseline. HF, heart failure; PU, partial unloading; CU,
complete unloading; W, weeks. All values are expressed as means  standard deviations. *P<.05 versus control group; yP<.05 versus HF group; zP<.05
versus HF-CU group.mRNA expression remained at a normal level in the HF-PU
group and lower in the HF-CU group.
DISCUSSION
Using the 2 heterotopic transplantation models, we com-
pared b-adrenergic responsiveness of papillary muscles and
gene expressions in failing rat hearts under partial and com-
plete unloading. We observed that chronic partial unloading
but not complete unloading improved the functional re-
sponse to b-adrenergic stimulation by isoproterenol and nor-
malized mRNA expressions of BNP and b1- and b2-ARs in
failing rat hearts. These data suggest that partial loading helps
restore b-adrenergic responsiveness and reverse mRNA ex-
pression downregulation during mechanical unloading.
LVAD provides ventricular unloading, and the timing of ini-
tiation of the LVAD ejection can control loading and unload-
ing. The counterpulsation mode of LVAD does not allow the
native aortic valve to open, and there is no flow through the
aortic valve. Therefore, the pump captures the entire cardiac
output, and the left ventricle is completely unloaded. The
methods of 2 heterotopic transplantation models can create
2 types of unloading situation (partial and complete unload-
ing) of the left ventricle for simulating the LVAD support.
b-ARs (b1 and b2 subtypes) are the primary myocardial
targets of the sympathetic neurotransmitter norepinephrine
and the adrenal hormone epinephrine. Activation of b-ARs468 The Journal of Thoracic and Cardiovascular Suin the heart leads to positive chronotropic and inotropic ac-
tion.9 Although long-term inotropic therapy based on en-
hanced b-AR stimulation is likely detrimental, b-AR
stimulation remains the most efficient way to enhance car-
diac contractile function acutely. Muscles taken from
LVAD hearts produced an inotropic response to isoprotere-
nol that was similar to that measured in nonfailing muscles
and significantly better than that measured in muscle from
failing hearts without LVAD.10 Dipla and colleagues11 re-
ported that b-adrenergic responsiveness of isolated myo-
cytes could be recovered after LVAD support. To measure
the cardiac inotropic response to b-adrenergic stimulation
by isoproterenol, we used the posterior papillary muscle in
this study. As previously demonstrated,12 the posterior pap-
illary muscle is not infarcted after the ligation of LAD and
can be used for functional studies of the noninfarcted myo-
cardium of the rats with MI. Isoproterenol is a nonselective
b-adrenergic agonist, which stimulates both b1- and b2-AR.
In the present study, we demonstrated that papillary muscle
from failing left ventricle under partial unloading produced
a significantly better inotropic response to isoproterenol
than those from failing left ventricle under complete unload-
ing and failing left ventricle at 4 weeks after transplantation
but not at 2 weeks after transplantation. We suggest that
chronic partial unloading contributes to the recovery of the
inotropic response to b-adrenergic stimulation in the failingTABLE 3. Expression of BNP, SERCA2a, b1- and b2-AR mRNAs in noninfarcted myocardium
Control
(n ¼ 7)
HF
(2 wk), n ¼ 8
HF-PU
(2 wk), n ¼ 8
HF-CU
(2 wk), n ¼ 7
HF
(4 wk), n ¼ 8
HF-PU
(4 wk), n ¼ 8
HF-CU
(4 wk), n ¼ 7
BNP/GAPDH 0.13  0.02 0.32  0.08* 0.20  0.05y 0.18  0.07y 0.49  0.16* 0.17  0.04yz 0.39  0.12*
SERCA2a/GAPDH 0.15  0.03 0.11  0.01* 0.15  0.01y 0.14  0.01y 0.07  0.02* 0.08  0.02* 0.07  0.02*
b1-AR/GAPDH 0.14  0.03 0.07  0.02* 0.13  0.02yz 0.06  0.02* 0.06  0.02* 0.11  0.03yz 0.05  0.01*
b2-AR/GAPDH 0.12  0.04 0.07  0.01* 0.15  0.02y 0.13  0.04y 0.06  0.02* 0.12  0.04yz 0.04  0.02*
BNP, Brain natriuretic peptide; SERCA2a, saco(endo)plasmic reticulum Ca2þ-ATPase2a; AR, adrenergic receptor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HF, heart
failure; PU, partial unloading; CU, complete unloading. *P< .05 versus control group; yP< .05 versus HF group; zP< .05 versus HF-CU group at the same time point.rgery c February 2009
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Prat hearts. Ogletree-Hughes and colleagues10 also demon-
strated that patients supported for a longer time had greater
recovery of inotropic response, suggesting that factors in ad-
dition to duration contribute to variability in recovery of the
inotropic response.
We measured the mRNA expressions of b1- and b2-AR in
the noninfarcted myocardium. b1-AR is the predominant
subtype, approaching 70% to 80% of total b-ARs, but func-
tional coupling to contractility has been demonstrated for the
b2 subtype.
13 It is generally accepted that in the process of
HF, the density and affinity of b-ARs are known to decrease
and lead to a deterioration in cardiac function. In the present
study, we have shown that partial unloading can lead to up-
regulation of myocardial b1- and b2-AR mRNA expressions
to near normal levels. It was thought that the recovery of b-
ARs mRNA was due to hemodynamic factors resulting from
the unloading extent of failing left ventricle because only b2-
AR mRNA expression was improved in failing left ventricle
under complete unloading at 2 weeks after transplantation,
then it decreased at 4 weeks after transplantation. The dif-
ferences of b-AR mRNA expressions suggest that chronic
partial unloading can restore both b1- and b2-AR mRNA ex-
pressions, resulting in the recovery of inotropic response to
b-adrenergic stimulation by isoproterenol. In our previous
study,5 only b2-AR mRNA expression was normalized in
failing rat hearts for 2 weeks’ complete unloading. Tevaearai
and associates14 demonstrated that the overexpression of b2-
AR potentiated the functional recovery of unloaded (com-
plete unloading) failing rabbit hearts. Cardiac b2-receptor
subtype acts preferentially to increase the opening of plasma
membrane calcium channels. Overexpression of the b2-AR
resulted in marked enhancement of LV contractility as as-
sessed by the maximal first derivative of LV pressure, dP/
dtmax, compared with negative littermate controls in the
transgenic mice.15 Recently, b2-agonist has been shown to
have a beneficial effect on LV remodeling after MI in a rat
model.16 Furthermore, stimulation of cardiac myocyte with
b2-agonist seems to give protection against apoptosis.
17
In the present study, we also measured the BNP mRNA
expression. BNP is a member of the natriuretic peptide
family synthesized and secreted in the cardiac ventricle in re-
sponse to cardiomyocyte stretch.18 Increased plasma BNP
correlated with LV dilatation or ventricular stiffness.19 We
have shown that the mRNA expression of BNP was normal-
ized in both the HF-CU and HF-PU groups at 2 weeks after
transplantation, but it remained at the normal level in the
HF-PU group but increased in the HF-CU group at 4 weeks
after transplantation. Therefore, we suggest that chronic and
severe (complete) unloading causes too much reduction of
ventricular volume and wall tension, which can impair the
functional recovery. We do not know what extent of LV un-
loading is appropriate for induction of ‘‘reverse remodeling’’
and functional recovery, but we suggest that it is important to
keep appropriate LV tension under LVAD support.The Journal of Thoracic and CRecent clinical reports in some patients with end-stage HF
have demonstrated that LVAD can improve cardiac function
and be used as a ‘‘bridge to recovery’’ without heart trans-
plantation.2,20 However, its success rate as a bridge to recov-
ery is low.21 Although our data have shown that chronic
partial unloading may result in recovery of b-adrenergic re-
sponsiveness, we also found that both HF-PU and HF-CU
caused a time-dependent depression in baseline DT of pap-
illary muscle. DT decreased under the normal levels at 4
weeks after transplantation, although the contractility was
significantly improved compared with that of failing hearts.
Furthermore, the mRNA expression of SERCA2a also de-
creased at 4 weeks after transplantation in both the HF-PU
and HF-CU groups. Therefore, we suggest that long-term
unloading can result in a time-dependent depression of the
reversion of contractility and SERCA2a mRNA expression.
Some reports have shown similar results. Bartling and col-
leagues22 demonstrated that LV transcription of SERCA2a
as well as of Naþ–Ca2þ exchanger remained at failing levels
despite LVAD support in some patients. Ito and associates23
demonstrated that chronic complete unloading of normal rat
hearts caused depression of myocyte contractile reserve and
impaired [Ca2þ]i handing in association with a reduced SER-
CA2a-to-phospholamban (PLB) protein ratio. Cardiac un-
loading by LVAD for a very long duration in patients with
HF may induce cardiac atrophy and depress contractility.
However, the optimal duration of mechanical unloading
was not clear. Xydas and colleagues24 demonstrated that car-
diac recovery peaked by 60 days, and echocardiography,
electrocardiography, histology, and neurohormone were
improved during LVAD support.
This study has some limitations. First, heterotopic trans-
plantation necessitates an organ harvest, a short duration
of cardiac ischemia, and surgical implantation in another
rat. We should consider the influence of ischemia during car-
diac arrest. All transplantation procedures took<40 minutes,
and we used cold cardioplegic solution and ice protection
during the procedures. Thus, we believed the ischemic influ-
ences would be minimal. Second, we chose to study the iso-
lated posterior papillary muscle to assess the myocardial
functional ‘‘recovery’’ of failing hearts. The effects of un-
loading are thought to encompass not only changes at the
cellular level but also regional and global function as part
of the remodeling process. Therefore, whether the results
of papillary muscle can reflect the global LV function pre-
cisely is unknown. Third, in this study, the mRNA levels
were measured, not the protein levels. Therefore, it is unde-
termined whether the alteration of mRNA precisely reflected
protein expression. Finally, as transplantation technique ren-
ders the grafted heart denervated, b-AR might be influenced
by the absence of direct neural stimulation rather than un-
loading. A previous report has suggested that restoration
of b-AR density is independent of cardiac denervation.14
Therefore, we believe that the improvement of b-ARardiovascular Surgery c Volume 137, Number 2 469
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PmRNA expression appears to be due to unloading rather than
denervation.
In summary, we have shown that chronic partial unload-
ing but not complete unloading of failing rat hearts results
in recovery of the ability of papillary muscle to respond to
b-adrenergic stimulation by isoproterenol and normalizes
BNP and b1- and b2-AR mRNA expressions. The differ-
ences of inotropic response and mRNA expressions may
be related to the extent of unloading of failing rat hearts.
The present study also showed a time-dependent depression
in baseline contractility of papillary muscle both in partial
and complete unloading, which may have a relation with
the trend toward myocyte atrophy and downregulation of
SERCA2a mRNA expression.
We thank Mrs. F. Kataoka for her histologic assistance.
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